title: Arterially directed therapies for hepatocellular carcinoma.
abstract: OBJECTIVE
  Arterially directed therapies for hepatocellular carcinoma are used for patients who are not candidates for surgery or ablation and for those who need a bridge or down-staging to liver transplantation. These therapies seem to prolong the overall survival when compared with supportive care.
  
  
  CONCLUSIONS
  Chemoembolization, particle embolization, drug-eluting beads, and radioembolization have been used for locoregional control. This review discusses patient selection, techniques, safety, clinical outcomes, and imaging findings related to these therapies.
authors.affiliation: Department of Radiology, Interventional Radiology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Ste H118, New York, NY 10065, USA.
authors.forename: Rajesh P
authors.initials: RP
authors.lastname: Shah
authors.forename: Karen T
authors.initials: KT
authors.lastname: Brown
authors.forename: Constantinos T
authors.initials: CT
authors.lastname: Sofocleous
mesh_terms: D001158:Arteries; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D003952:Diagnostic Imaging; D016503:Drug Delivery Systems; D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D008863:Microspheres; D009367:Neoplasm Staging / Q000379:methods*; D018579:Patient Selection